[Immunohistochemistry in the diagnosis and treatment of breast cancer].
Immunohistochemical staining (immunostaining) has been frequently used with breast cancer in order to give definite histological diagnosis and information for treatment or prognosis. In the histological diagnosis, immunostaining is used for differential diagnoses of tumor origin and malignancy. Immunostainings for hormone receptors and c-erbB-2 are useful for the prediction of the effect of endocrine therapy and prognosis. In the future, more important substances examined by immunohistochemistry are awaited for the diagnosis and treatment of the breast cancer.
Matsuura
N
N
Dept. of Molecular Pathology, Osaka University Medical School, Japan.
Ohnishi
A
A
Itoh
Y
Y
Wakasugi
E
E
Tsujimoto
M
M
D001943:Breast Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis
D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen